|
DE19856475A1
(de)
|
1998-11-27 |
2000-05-31 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
DE10346940B3
(de)
*
|
2003-10-06 |
2005-06-16 |
Schering Ag |
Substituierte Pentanole, ihre Verwendung zur Herstellung von Arzneimitteln speziell Entzündungshemmer sowie diese enthaltende pharmazeutische Präparate
|
|
AU2002219218A1
(en)
*
|
2000-12-28 |
2002-07-16 |
Schering Ag |
Method for screening for progesterone receptor isoform-specific ligands
|
|
AU2003202216A1
(en)
*
|
2002-01-14 |
2003-07-30 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
|
|
EP1344776A1
(en)
*
|
2002-03-11 |
2003-09-17 |
Schering Aktiengesellschaft |
5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders
|
|
PL372490A1
(en)
*
|
2002-03-11 |
2005-07-25 |
Schering Aktiengesellschaft |
5-{2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino}-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy
|
|
WO2003082787A1
(en)
|
2002-03-26 |
2003-10-09 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
CA2478156C
(en)
|
2002-03-26 |
2011-02-15 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
DE10215316C1
(de)
*
|
2002-04-02 |
2003-12-18 |
Schering Ag |
Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
|
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
JP2006504678A
(ja)
|
2002-08-21 |
2006-02-09 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
グルココルチコイドミメチックス、その製造方法、その医薬組成物、及び使用
|
|
WO2004019935A1
(en)
|
2002-08-29 |
2004-03-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
-3 (sulfonamidoethyl) -indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
|
|
EP1562906A4
(en)
*
|
2002-10-15 |
2009-12-02 |
Univ Tennessee Res Foundation |
HETEROCYCLIC SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHOD FOR THEIR USE
|
|
DE10261874A1
(de)
*
|
2002-12-20 |
2004-07-08 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
CA2512257A1
(en)
|
2003-01-03 |
2004-07-29 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
|
|
US20040224992A1
(en)
*
|
2003-02-27 |
2004-11-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
EA200600148A1
(ru)
*
|
2003-07-01 |
2006-08-25 |
Шеринг Акциенгезельшафт |
Гетероциклически замещённые производные пентанола, способ их получения и их применение в качестве ингибиторов воспаления
|
|
GB0316290D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
|
UY28526A1
(es)
|
2003-09-24 |
2005-04-29 |
Boehringer Ingelheim Pharma |
Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
|
|
US7507843B2
(en)
|
2003-10-16 |
2009-03-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
|
|
US7795272B2
(en)
|
2004-03-13 |
2010-09-14 |
Boehringer Ingelheim Pharmaceutical, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
|
|
PE20060272A1
(es)
|
2004-05-24 |
2006-05-22 |
Glaxo Group Ltd |
(2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
|
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
|
DE102004062182B4
(de)
*
|
2004-12-20 |
2007-06-06 |
Bayer Schering Pharma Ag |
Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff
|
|
CA2592514A1
(en)
|
2004-12-27 |
2006-07-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
EP1841780B1
(en)
|
2005-01-10 |
2011-07-27 |
Glaxo Group Limited |
Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
|
|
JPWO2006083030A1
(ja)
*
|
2005-02-04 |
2008-06-26 |
味の素株式会社 |
脂肪酸の製造方法および脂肪酸の塩結晶
|
|
MY145343A
(en)
|
2005-03-25 |
2012-01-31 |
Glaxo Group Ltd |
Novel compounds
|
|
PE20061193A1
(es)
|
2005-03-25 |
2006-12-02 |
Glaxo Group Ltd |
DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2-[1H]-0NA COMO INHIBIDORES DE QUINASA p38
|
|
DE102005017326A1
(de)
*
|
2005-04-14 |
2007-03-29 |
Schering Ag |
Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
|
|
DE102005030294A1
(de)
*
|
2005-06-24 |
2007-01-04 |
Schering Ag |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
DE102005030293A1
(de)
*
|
2005-06-24 |
2007-01-04 |
Schering Ag |
Verwendung von nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
US7408060B2
(en)
|
2005-06-24 |
2008-08-05 |
Schering Ag |
Nonsteroidal progesterone receptor modulators
|
|
GB0514809D0
(en)
|
2005-07-19 |
2005-08-24 |
Glaxo Group Ltd |
Compounds
|
|
WO2007065828A1
(en)
|
2005-12-09 |
2007-06-14 |
F. Hoffmann-La Roche Ag |
Glucocorticoid receptor modulators as antiinflammatory agents
|
|
PE20071068A1
(es)
|
2005-12-20 |
2007-12-13 |
Glaxo Group Ltd |
Acido 3-(4-{[4-(4-{[3-(3,3-dimetil-1-piperidinil)propil]oxi}fenil)-1-piperidinil]carbonil}-1-naftalenil)propanoico o propenoico, sales de los mismos, como antagonistas de los receptores h1 y h3
|
|
MX2008013411A
(es)
|
2006-04-20 |
2008-11-04 |
Glaxo Group Ltd |
Nuevos compuestos.
|
|
GB0611587D0
(en)
|
2006-06-12 |
2006-07-19 |
Glaxo Group Ltd |
Novel compounds
|
|
AU2007329548A1
(en)
|
2006-12-06 |
2008-06-12 |
Boehringer Ingelheim International Gmbh |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
UY30805A1
(es)
*
|
2006-12-21 |
2008-07-31 |
Bayer Schering Pharma Ag |
Moduladores no esteroides de receptores de progesterona
|
|
UY30815A1
(es)
*
|
2006-12-21 |
2008-07-31 |
Bayer Schering Pharma Ag |
Moduladores no esteroidales del receptor de progesterona
|
|
DE102007049630A1
(de)
|
2007-10-11 |
2009-10-29 |
Bayer Schering Pharma Aktiengesellschaft |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
DE102007023614A1
(de)
|
2007-05-21 |
2008-11-27 |
Bayer Schering Pharma Aktiengesellschaft |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
JP5090773B2
(ja)
|
2006-12-26 |
2012-12-05 |
国立大学法人東京工業大学 |
光学活性含フッ素カルボニル−エン生成物の製造方法
|
|
PE20081889A1
(es)
|
2007-03-23 |
2009-03-05 |
Smithkline Beecham Corp |
Indol carboxamidas como inhibidores de ikk2
|
|
DE102007032800A1
(de)
|
2007-07-10 |
2009-01-15 |
Bayer Schering Pharma Aktiengesellschaft |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
DE102007058747A1
(de)
|
2007-12-05 |
2009-06-10 |
Bayer Schering Pharma Aktiengesellschaft |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
EP2070909A1
(de)
*
|
2007-12-15 |
2009-06-17 |
Bayer Schering Pharma AG |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
MX2010012814A
(es)
|
2008-05-23 |
2010-12-20 |
Amira Pharmaceuticals Inc |
Inhibidor de proteina activadora de 5-lipoxigenasa.
|
|
ES2383246T3
(es)
|
2008-06-05 |
2012-06-19 |
Glaxo Group Limited |
4-amino-indazoles
|
|
US8163743B2
(en)
|
2008-06-05 |
2012-04-24 |
GlaxoGroupLimited |
4-carboxamide indazole derivatives useful as inhibitors of PI3-kinases
|
|
EP2300472B1
(en)
|
2008-06-06 |
2012-01-18 |
Boehringer Ingelheim International GmbH |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
WO2010094643A1
(en)
|
2009-02-17 |
2010-08-26 |
Glaxo Group Limited |
Quinoline derivatives and their uses for rhinitis and urticaria
|
|
JP5656880B2
(ja)
|
2009-03-09 |
2015-01-21 |
グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ |
Ｐｉ３キナーゼの阻害剤としての４−オキサジアゾール−２−イル−インダゾール
|
|
WO2010102968A1
(en)
|
2009-03-10 |
2010-09-16 |
Glaxo Group Limited |
Indole derivatives as ikk2 inhibitors
|
|
EP2408769A1
(en)
|
2009-03-17 |
2012-01-25 |
Glaxo Group Limited |
Pyrimidine derivatives used as itk inhibitors
|
|
EP2408458A1
(en)
|
2009-03-19 |
2012-01-25 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6 (STAT6) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
EP2408916A2
(en)
|
2009-03-19 |
2012-01-25 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
US20120029054A1
(en)
|
2009-03-19 |
2012-02-02 |
Merck Sharp & Dohme Corp. |
RNA Interference Mediated Inhibition of GATA Binding Protein 3 (GATA3) Gene Expression Using Short Intefering Nucleic Acid (siNA)
|
|
JP2012520684A
(ja)
|
2009-03-19 |
2012-09-10 |
メルク・シャープ・エンド・ドーム・コーポレイション |
低分子干渉核酸（ｓｉＮＡ）を用いたＢＴＢａｎｄＣＮＣＨｏｍｏｌｏｇｙ１（塩基性ロイシンジッパー転写因子１）（Ｂａｃｈ１）遺伝子発現のＲＮＡ干渉媒介性阻害
|
|
WO2010111497A2
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF THE INTERCELLULAR ADHESION MOLECULE 1 (ICAM-1)GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
JP2012521760A
(ja)
|
2009-03-27 |
2012-09-20 |
メルク・シャープ・エンド・ドーム・コーポレイション |
低分子干渉核酸（ｓｉＮＡ）を用いたアポトーシスシグナル調節キナーゼ１（ＡＳＫ１）遺伝子発現のＲＮＡ干渉媒介性阻害
|
|
WO2010111471A2
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
EP2411520A2
(en)
|
2009-03-27 |
2012-02-01 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF THE THYMIC STROMAL LYMPHOPOIETIN (TSLP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
EP2411018A2
(en)
|
2009-03-27 |
2012-02-01 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF THE NERVE GROWTH FACTOR BETA CHAIN (NGFß) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
|
|
EP2421834A1
(en)
|
2009-04-24 |
2012-02-29 |
Glaxo Group Limited |
Pyrazole and triazole carboxamides as crac channel inhibitors
|
|
AR076373A1
(es)
|
2009-04-24 |
2011-06-08 |
Glaxo Group Ltd |
N-pirazolil carboxamidas como inhibidores de canales de calcio
|
|
LT2899191T
(lt)
|
2009-04-30 |
2017-10-25 |
Glaxo Group Limited |
Oksazolo pakeistieji indazolai kaip pi3-kinazės inhibitoriai
|
|
JP2013512880A
(ja)
|
2009-12-03 |
2013-04-18 |
グラクソ グループ リミテッド |
Ｐｉ３−キナーゼ阻害剤としてのインダゾール誘導体
|
|
WO2011067364A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Novel compounds
|
|
WO2011067365A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Benzpyrazole derivatives as inhibitors of p13 kinases
|
|
EP3020393B1
(en)
|
2009-12-16 |
2020-10-07 |
3M Innovative Properties Company |
Formulations and methods for controlling mdi particle size delivery
|
|
WO2011110575A1
(en)
|
2010-03-11 |
2011-09-15 |
Glaxo Group Limited |
Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases
|
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
|
US9326987B2
(en)
|
2010-09-08 |
2016-05-03 |
Glaxo Group Limited |
Indazole derivatives for use in the treatment of influenza virus infection
|
|
RS54286B1
(sr)
|
2010-09-08 |
2016-02-29 |
Glaxosmithkline Intellectual Property Development Limited |
Polimorfi i soli n-[5-[4-(5-{[(2r,6s)-2,6-dimetil-4-morfolinil]metil}-1,3-oksazol-2-il)-1h-indazol-6-il]-2(metiloksi)-3-piridinil]-metansulfonamida
|
|
WO2012035055A1
(en)
|
2010-09-17 |
2012-03-22 |
Glaxo Group Limited |
Novel compounds
|
|
EP2630127A1
(en)
|
2010-10-21 |
2013-08-28 |
Glaxo Group Limited |
Pyrazole compounds acting against allergic, inflammatory and immune disorders
|
|
US9156791B2
(en)
|
2010-10-21 |
2015-10-13 |
Glaxo Group Limited |
Pyrazole compounds acting against allergic, immune and inflammatory conditions
|
|
GB201018124D0
(en)
|
2010-10-27 |
2010-12-08 |
Glaxo Group Ltd |
Polymorphs and salts
|
|
GB201104153D0
(en)
|
2011-03-11 |
2011-04-27 |
Glaxo Group Ltd |
Novel compounds
|
|
EP2683716A1
(en)
|
2011-03-11 |
2014-01-15 |
Glaxo Group Limited |
Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
|
|
KR20160060100A
(ko)
|
2013-09-22 |
2016-05-27 |
칼리토르 사이언시즈, 엘엘씨 |
치환된 아미노피리미딘 화합물 및 이용 방법
|
|
RU2016112268A
(ru)
|
2013-10-17 |
2017-11-22 |
Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Ингибитор PI3K для лечения респираторного заболевания
|
|
WO2015055691A1
(en)
|
2013-10-17 |
2015-04-23 |
Glaxosmithkline Intellectual Property Development Limited |
Pi3k inhibitor for treatment of respiratory disease
|
|
WO2015148867A1
(en)
|
2014-03-28 |
2015-10-01 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
|
US20170100385A1
(en)
|
2014-05-12 |
2017-04-13 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Pharmaceutical compositions comprising danirixin for treating infectious diseases
|
|
JP2018527362A
(ja)
|
2015-09-11 |
2018-09-20 |
サンシャイン・レイク・ファーマ・カンパニー・リミテッドＳｕｎｓｈｉｎｅ Ｌａｋｅ Ｐｈａｒｍａ Ｃｏ．，Ｌｔｄ． |
置換されたヘテロアリール化合物および使用方法
|
|
GB201602527D0
(en)
|
2016-02-12 |
2016-03-30 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
US20190161480A1
(en)
|
2016-08-08 |
2019-05-30 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical Compounds
|
|
GB201706102D0
(en)
|
2017-04-18 |
2017-05-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
GB201712081D0
(en)
|
2017-07-27 |
2017-09-13 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
EP3569228A1
(en)
*
|
2018-05-17 |
2019-11-20 |
Association pour la recherche à l'IGBMC (ARI) |
Non-steroidal selective glucocorticoid receptor agonistic modulators (segrams) and uses thereof
|
|
WO2019099311A1
(en)
|
2017-11-19 |
2019-05-23 |
Sunshine Lake Pharma Co., Ltd. |
Substituted heteroaryl compounds and methods of use
|
|
KR102737185B1
(ko)
|
2018-01-20 |
2024-12-05 |
선샤인 레이크 파르마 컴퍼니 리미티드 |
치환된 아미노피리미딘 화합물 및 이의 사용 방법
|
|
WO2021191875A1
(en)
|
2020-03-26 |
2021-09-30 |
Glaxosmithkline Intellectual Property Development Limited |
Cathepsin inhibitors for preventing or treating viral infections
|
|
CR20230007A
(es)
*
|
2020-06-12 |
2023-06-01 |
Shanghai Jemincare Pharmaceuticals Co Ltd |
Compuesto de ftalazinona, y método de preparación y uso médico de este.
|
|
CN114605308B
(zh)
*
|
2022-03-18 |
2023-12-19 |
阜新孚隆宝医药科技有限公司 |
一种帕罗韦德的氮杂双环医药中间体的制备方法及中间体
|